Interaction of 5-HTT/NPSR1 variants with distal and acute stress on dimensional and neuroendocrine anxiety endophenotypes – A multi-dimensional model of anxiety risk
The etiology of anxiety disorders is multifactorial with contributions from both genetic and environmental factors. Several susceptibility genes of anxiety disorders or anxiety-related intermediate phenotypes have been identified, including the serotonin transporter gene (5-HTT) and the neuropeptide S receptor gene (NPSR1), which have been shown to modulate responses to distal and acute stress experiences. For instance, gene-environment interaction (GxE) studies have provided evidence that both 5-HTT and NPSR1 interact with environmental stress, particularly traumatic experiences during childhood, in the moderation of anxiety traits, and both 5-HTT and NPSR1 have been implicated in hypothalamic-pituitary-adrenal (HPA) axis reactivity – an intermediate phenotype of mental disorders – in response to acute stress exposure. The first part of this thesis aimed to address the interplay of variations in both 5-HTT and NPSR1 genes and distal stress experiences, i.e. childhood trauma, in the moderation of anxiety-related traits, extended by investigation of the potentially protective effect of positive influences, i.e. elements of successful coping such as general self-efficacy (GSE), on a GxE risk constellation by introducing GSE as an indicator of coping ability (“C”) as an additional dimension in a GxExC approach conferring – or buffering – vulnerability to anxiety. Increased anxiety was observed in 5-HTTLPR/rs25531 LALA genotype and NSPR1 rs324981 AA genotype carriers, respectively, with a history of childhood maltreatment but only in the absence of a person’s ability to cope with adversity, whereas a dose-dependent effect on anxiety traits as a function of maltreatment experiences irrespective of coping characteristics was observed in the presence of at least one 5-HTT S/LG or NSPR1 T allele, respectively. The second part of this thesis addressed the respective impact of 5-HTT and NPSR1 variants on the neuroendocrine, i.e. salivary cortisol response to acute psychosocial stress by applying the Maastricht Acute Stress Test (MAST). A direct effect of NPSR1 – but not 5-HTT – on the modulation of acute stress reactivity could be discerned, with carriers of the more active NPSR1 T allele Summary III displaying significantly higher overall salivary cortisol levels in response to the MAST compared to AA genotype carriers. In summary, study 1 observed a moderating effect of GSE in interaction with childhood maltreatment and 5-HTT and NPSR1, respectively, in an extended GxExC model of anxiety risk, which may serve to inform targeted preventive interventions mitigating GxE risk constellations and to improve therapeutic interventions by strengthening coping ability as a protective mechanism to promote resilient functioning. In study 2, a modulation of HPA axis function, considered to be an endophenotype of stress-related mental disorders, by NPSR1 gene variation could be discerned, suggesting neuroendocrine stress reactivity as an important potential intermediate phenotype of anxiety given findings linking NPSR1 to dimensional and categorical anxiety. Results from both studies may converge within the framework of a multi-level model of anxiety risk, integrating neurobiological, neuroendocrine, environmental, and psychological factors that act together in a highly complex manner towards increasing or decreasing anxiety risk.
Read more
